Business Wire

Amazfit Introduces a New Era of Hybrid Training with Balance 3 and Balance Ultra

2.6.2026 19:00:00 CEST | Business Wire | Press Release

Share

Amazfit, a leading global smart wearable brand owned by Zepp Health, today unveiled the Amazfit Balance 3 and Amazfit Balance Ultra, the newest additions to the Balance series and the hero watches for Amazfit’s new Hybrid Training System, connecting performance tracking with intelligent training guidance through the Zepp App.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260602329170/en/

Built around how modern athletes train today, Balance 3 and Balance Ultra are designed for people balancing strength, endurance, recovery, work, stress, and daily life. The devices serve as the engine layer of the connected Hybrid Training ecosystem, capturing how users train, recover, and respond over time.

The products were unveiled at a launch event in New York during a panel hosted by leading voices from the fitness and HYROX community. Built around how modern athletes train today, Balance 3 and Balance Ultra are designed for people balancing strength, endurance, recovery, work, stress, and daily life. The devices serve as the engine layer of the connected Hybrid Training ecosystem, capturing how users train, recover, and respond over time, while the Zepp App serves as the intelligence layer, organizing that data into clearer direction.

Balance Ultra is the flagship expression of the Balance series, combining Grade 5 titanium craftsmanship with a refined performance design that moves naturally between training, work, and daily life. Balance 3 is built for everyday hybrid athletes who want one watch for the gym, running, recovery, and daily performance. It is available in stainless steel and titanium options, giving users a choice between durable everyday construction and a lighter premium build.

“The future of training is not about doing more without direction. It is about training with structure,” said Wayne Huang, CEO of Zepp Health. “With Balance 3 and Balance Ultra, we are helping athletes better understand how strength, endurance, recovery, and daily life all affect performance. The Balance series brings those signals together so users can understand their capacity, manage effort, and make more informed training decisions over time.”

A Hybrid Training System Built to Help Athletes Train with Structure

Modern training is becoming more hybrid. Athletes are running, lifting, conditioning, recovering, traveling, working, and managing daily stress, often all at once. The challenge is no longer just collecting more data. The challenge is understanding what that data means for how to train, when to push, when to recover, and how to stay consistent over time.

At the center of the Balance experience is the Zepp App, the intelligence layer of the Hybrid Training System. Balance 3 and Balance Ultra collect the data, while the Zepp App connects training, recovery, sleep, stress, and lifestyle data into a clearer view of how the body is adapting and what to prioritize next.

Within the app, HybridCharge Energy Intelligence brings this system together by combining BioCharge, LifeLoad, and Training Load into one view of capacity. BioCharge reflects the body’s energy and recovery state, LifeLoad adds context from daily stress and lifestyle demands, and Training Load shows the strain created by exercise. Together, these inputs help users better understand what they can sustain in the moment and how to manage effort across training and recovery.

Weekly Focus and Training Balance help users see whether their training is aligned across strength, endurance, and recovery, while Hybrid Training Plans bring more structure to preparation and progression. The result is a system designed to turn connected health and fitness signals into clearer direction, not just more data.

Built for Every Part of Training

Balance 3 and Balance Ultra are built to support the full rhythm of modern training, from structured workouts to recovery, navigation, communication, and daily wear. Both models feature bright 1.5-inch AMOLED displays with sapphire glass and up to 3,000-nit brightness, advanced health monitoring, precision dual-band GPS, six-satellite positioning systems, route guidance, offline map support, strength training support, and official HYROX tools in one connected experience.

Battery life is designed to keep pace with demanding schedules. Balance 3 delivers up to 21 days of battery life, while Balance Ultra extends that endurance further with up to 30 days of battery life, giving users a longer-lasting flagship option for consistent training, travel, and everyday wear.

The Balance series also supports a deeper view of health and recovery, with advanced metrics including heart rate, HRV, sleep, stress, blood oxygen, and breathing rate. For strength training, both watches support 25 auto-recognized strength exercises, helping users track effort across gym sessions without manually logging every movement. Bluetooth calling, Zepp Flow voice control, voice notes, and onboard storage help users stay connected and in control without interrupting their rhythm.

Official HYROX Tools for Training and Race Day

As Amazfit continues as the official wearable partner of HYROX, Balance 3 and Balance Ultra serve as the ultimate tools for HYROX training and racing.

Built-in HYROX features connect structured preparation with race-day execution. HYROX training plans, race simulations, HYROX Virtual Pace, and race-specific workout support help athletes prepare with greater intention.

Post-race analysis helps users better understand pacing, station performance, rankings, cumulative race time, and where performance was gained or lost. These tools are designed to support HYROX athletes while also reinforcing the broader Hybrid Training System: strength, endurance, recovery, and structure working together.

Pricing and Availability

  • The Amazfit Balance 3 Stainless Steel will be available starting June 2, 2026, for $369.99.
  • The Amazfit Balance 3 Titanium will be coming soon, for $449.99.
  • The Amazfit Balance Ultra will be available starting June 2, 2026, for $599.99.

All models will be available on Amazfit.com.

About Amazfit

Amazfit, a global smart wearable and fitness leader is part of Zepp Health (NYSE: ZEPP), a health technology company with its principal office based in Gorinchem, the Netherlands. Zepp Health operates as a distributed organization, with team members and offices across the Americas, Europe, Asia, and other global markets.

Amazfit builds smart wearables designed around movement — training with intention, recovery with balance, and evolution over time. Built for the way people train today, Amazfit blends endurance, strength, and recovery into a single, coherent rhythm to support sustainable progress over time.

Behind Amazfit is Zepp, which builds the intelligence that supports its training experience. For more information, visit www.amazfit.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260602329170/en/

Contacts

Media Contacts
Max Borges Agency for Amazfit
amazfit@maxborgesagency.com

Mary Thompson Woodbury
Head of PR, Amazfit North America
Mary.woodbury@zepp.com

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

SINOVAC Regained Compliance With the Nasdaq Global Market’s Listing Requirements15.6.2026 12:00:00 CEST | Press Release

Sinovac Biotech Ltd. (Nasdaq: SVA) ("SINOVAC" or the "Company"), a leading provider of biopharmaceutical products in China, today announced that it received a notification letter dated June 10, 2026 (the "Notification Letter"), from Hearing Advisor of The Nasdaq Stock Market LLC., indicating that the Company has regained compliance with Listing Rule 5250(c)(1) and that the Company is therefore in compliance with the Nasdaq Global Market's listing requirements. As noted in the Hearing Panel's May 20, 2026 compliance determination, the Company remains under a Mandatory Panel Monitor pursuant to Listing Rule 5815(d)(4)(B) until May 20, 2027. The Company filed its annual report on Form 20-F for the year ended December 31, 2025 on June 5, 2026. The Notification Letter also stated that the hearing before the Hearings Panel, applied for by the Company, had accordingly been canceled. About SINOVAC Sinovac Biotech Ltd. (SINOVAC) is a China-based global biopharmaceutical company, with a mission

KRM22 partners with Sigma AI to enhance market surveillance and risk intelligence capabilities15.6.2026 12:00:00 CEST | Press Release

KRM22, the technology and software investment company focused on risk management solutions for capital markets, today announced a strategic partnership with Sigma AI, a leading provider of AI-driven financial insights, to integrate advanced news sentiment analytics into its risk management application suite. The integration marks a significant enhancement to KRM22’s capabilities, enabling clients to incorporate real-time market sentiment insights derived from global news sources directly into their risk frameworks. By leveraging Sigma AI’s proprietary natural language processing and machine learning models, KRM22 will help firms better identify emerging risks, anticipate market-moving events, and make more informed trading and compliance decisions. Advancing risk management through AI-driven sentiment analysis As part of the first phase of the collaboration, KRM22 will embed Sigma AI’s news sentiment engine within its application suite. This will provide users with actionable intellige

HUI (HUI:VSE) Merges Traditional and Crypto Finance: Commences Continuous Trading in Vienna With Leading Market Maker and Announces Impending Token Listing on Major Global Exchange15.6.2026 11:15:00 CEST | Press Release

HUI S.p.A., the pioneering vertical SuperApp and SaaS company dedicated to the global Venture Capital and startup ecosystem listed on the Vienna Stock Exchange, today released its global product strategy, marking an unprecedented convergence between traditional regulated markets and decentralized finance. Driven by a +15% stock surge and the consolidation of its $25 million round a equity commitment fully subscribed by global institutional fund Nimbus Capital, the company announced its upcoming transition to continuous trading on the Vienna market in partnership with a leading European market maker, alongside the activation of the initial PUT options tied to the round. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612936893/en/ HUI (HUI:VSE) merges traditional and crypto finance: commences continuous trading in Vienna with leading market maker and announces impending token listing on major global exchange Emmanuelle Deba

Syngenta Signs MoU to Be Strategic Partner in India’s First Open-Data Agricultural Ecosystem Annam.AI15.6.2026 09:35:00 CEST | Press Release

India’s agriculture sector is a global powerhouse, uniquely characterized by its massive scale, vast arable land, diverse agro-climatic zones and rich biodiversity. These strengths have propelled the country to become one of the world’s leading producers of crops such as rice and wheat. However, farmers in the country face significant challenges – from erratic monsoons, severe droughts and unseasonal rains compounded by El Nino, to pests and diseases that destroy an estimated 30 percent of crops annually. More than 80 percent of India’s estimated 150 million farming households are composed of smallholder farmers who operate on less than two hectares of land. This limits economies of scale, sets obstacles to the wider adoption of advanced technologies and could widen a systemic gap between large commercial agricultural operations and the bulk of its farming population. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/202606151544

Pelago Bioscience Acquires RG Discovery, Forming an Integrated Drug Discovery Partner Spanning Biology and Chemistry15.6.2026 09:00:00 CEST | Press Release

Pelago Bioscience, a specialist drug discovery focused contract research organization (CRO), known for its industry-leading cell-based target engagement assays, is pleased to announce the acquisition of RG Discovery, and thereby adding deep expertise in medicinal chemistry, custom synthesis, and integrated drug discovery. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260615340933/en/ Michael Dabrowski, Chief Executive Officer of Pelago Bioscience By combining Pelago Bioscience's biology-focused capabilities with RG Discovery's chemistry expertise, the enlarged platform will enable drug discovery teams to accelerate decision-making, streamline workflows, and advance programs more efficiently from hit identification through lead optimization. "Drug discovery increasingly requires seamless integration between chemistry and biology," said Michael Dabrowski, Chief Executive Officer of Pelago Bioscience. "By bringing RG Discovery

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye